BriaCell Therapeutics Corp.

BCTXNASDAQ Capital Market·USD·Closed

BCTXNASDAQ·USD·Closed

$3.26

−1.51%

$3.26

−$0.05 (1.51%)

52W Range

1thpctl

Volume

0.45×avg

Mkt Cap

6.14MUSD

P/E

-0.7TTM

Div Yield

–ann

Healthcare · Biotechnology

52W Range

1thpctl

Volume

0.45×avg

Market Cap

6.14MUSD

P/E Ratio

-0.7TTM

Div Yield

-ann

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-136.3%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage-1080.2×

Current ratio7.07×

Continue with finqOS

Unlock the full picture

SEC filings, earnings transcripts, insider trades, institutional ownership, 175+ screening metrics, and an infinite research canvas.

14-day free trial · No credit card required